
Cystic Fibrosis Foundation
North America, Maryland, United States, Bethesda
Description
Cystic Fibrosis Foundation is the world’s leader in the search for a cure for cystic fibrosis.
Investor Profile
Cystic Fibrosis Foundation has backed more than 17 startups, with 3 new investments in the last 12 months alone. The firm has led 3 rounds, about 18% of its total and boasts 18 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Israel, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Led 2 rounds in the past year.
Stage Focus
- Post Ipo Equity (24%)
- Series C (18%)
- Series B (18%)
- Series A (12%)
- Series Unknown (12%)
- Grant (6%)
- Convertible Note (6%)
- Undisclosed (6%)
Country Focus
- United States (53%)
- Israel (24%)
- United Kingdom (18%)
- Canada (6%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Genetics
- Medical
- Health Diagnostics
- Medical Device
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Cystic Fibrosis Foundation frequently co-invest with?
What are some of recent deals done by Cystic Fibrosis Foundation?
Find More Investors Like Cystic Fibrosis Foundation
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










